We are live on ! Find out more
CTA

Chesley Taft & Associates Portfolio holdings

AUM $2.57B
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+22.93%
3 Year Est. Return
+80.85%
5 Year Est. Return
+97.37%
10 Year Est. Return
+353.09%
AUM
$933M
AUM Growth
-$70.2M
Cap. Flow
-$83.2M
Cap. Flow %
-8.91%
Top 10 Hldgs %
21.05%
Holding
287
New
19
Increased
103
Reduced
83
Closed
38

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$6.14M
2
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$3.32M
3
CVS icon
CVS Health
CVS
+$2.81M
4
MA icon
Mastercard
MA
+$2.67M
5
HSY icon
Hershey
HSY
+$2.53M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$14.6M
2
VOD icon
Vodafone
VOD
+$12.5M
3
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$8.8M
4
IBM icon
IBM
IBM
+$7.24M
5
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$6.15M

Sector Composition

Rank Sector Weight
1 Healthcare 19.36%
2 Industrials 15.61%
3 Technology 12.01%
4 Consumer Staples 10.55%
5 Energy 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OXY icon
51
Occidental Petroleum
OXY
$56.8B
$6.79M 0.73%
74,411
+2,662
+4% +$238K
KSS icon
52
Kohl's
KSS
$2.17B
$6.36M 0.68%
111,918
+800
+0.7% +$42.9K
SLB icon
53
SLB Ltd
SLB
$73.6B
$6.33M 0.68%
64,913
+2,830
+5% +$256K
JPM icon
54
JPMorgan Chase
JPM
$935B
$6.23M 0.67%
102,605
+880
+0.9% +$50.9K
NVS icon
55
Novartis
NVS
$297B
$5.97M 0.64%
78,333
+1,018
+1% +$74.2K
MDY icon
56
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$5.96M 0.64%
23,765
+575
+2% +$141K
ECYT
57
DELISTED
Endocyte, Inc. Common Stock
ECYT
$5.87M 0.63%
246,550
+22,000
+10% +$319K
AMZN icon
58
Amazon
AMZN
$2.92T
$5.8M 0.62%
345,060
+11,360
+3% +$211K
APH icon
59
Amphenol
APH
$198B
$5.78M 0.62%
504,072
+10,400
+2% +$116K
K
60
DELISTED
Kellanova
K
$5.62M 0.6%
95,381
+1,491
+2% +$84.6K
SRCL
61
DELISTED
Stericycle Inc
SRCL
$5.59M 0.6%
49,170
+615
+1% +$71.1K
ICE icon
62
Intercontinental Exchange
ICE
$85.6B
$5.55M 0.6%
140,365
+1,025
+0.7% +$43.3K
ABBV icon
63
AbbVie
ABBV
$443B
$5.37M 0.58%
104,416
+1,292
+1% +$65.3K
GWW icon
64
W.W. Grainger
GWW
$65.3B
$5.27M 0.56%
20,865
+70
+0.3% +$17.5K
J icon
65
Jacobs Solutions
J
$15.9B
$5.11M 0.55%
97,275
+219
+0.2% +$11.3K
MA icon
66
Mastercard
MA
$506B
$5.07M 0.54%
67,800
+34,200
+102% +$2.67M
NTRS icon
67
Northern Trust
NTRS
$22.4B
$5.03M 0.54%
76,759
+679
+0.9% +$42.1K
PX
68
DELISTED
Praxair Inc
PX
$4.58M 0.49%
34,989
-200
-0.6% -$25.9K
PG icon
69
Procter & Gamble
PG
$336B
$4.29M 0.46%
53,212
-28,335
-35% -$2.23M
IBB icon
70
iShares Biotechnology ETF
IBB
$9.34B
$4.23M 0.45%
53,625
-150
-0.3% -$12.5K
HSY icon
71
Hershey
HSY
$35.5B
$4.15M 0.44%
39,720
+24,780
+166% +$2.53M
COST icon
72
Costco
COST
$422B
$4.02M 0.43%
36,032
+1,108
+3% +$127K
REGN icon
73
Regeneron Pharmaceuticals
REGN
$78.5B
$4.01M 0.43%
13,350
-50
-0.4% -$15.4K
MRK icon
74
Merck
MRK
$322B
$3.9M 0.42%
72,021
+682
+1% +$35.3K
TW
75
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$3.83M 0.41%
33,580
-17,015
-34% -$1.98M
1 2
3
4 5

Similar funds

GWP
Gateway Wealth Partners Appleton, Wisconsin $2.57B AUM 16.81% 1-Year Est. Return
PCM
Palestra Capital Management New York $2.57B AUM 29.93% 1-Year Est. Return
DCM
Dorsal Capital Management Redwood City, California $2.57B AUM 3.13% 1-Year Est. Return
RG
Rakuten Group Setagaya-Ku, Tokyo, Japan $2.58B AUM 250.19% 1-Year Est. Return
GFA
Gallagher Fiduciary Advisors Rolling Meadows, Illinois $2.58B AUM 8.97% 1-Year Est. Return
LS
Livforsakringsbolaget Skandia Stockholm, Sweden $2.58B AUM 30.64% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return

Chesley Taft & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Chesley Taft & Associates held 287 positions worth $933M, down 7% from $1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Chesley Taft & Associates withdrew a net $83.2M in Q1 2014, closing 38 positions and reducing 83 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $14.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

Against the trend, Chesley Taft & Associates opened a new position in SALIX PHARMACEUTICALS LTD DEL worth $3.36M.

  • Chesley Taft & Associates's largest Q1 2014 buy was SALIX PHARMACEUTICALS LTD DEL: 32,425 shares worth $3.36M.
  • Chesley Taft & Associates added most to Verizon in Q1 2014, an estimated $6.14M increase.
  • Chesley Taft & Associates's biggest Q1 2014 reduction was Vodafone, cutting an estimated $12.5M.
  • Chesley Taft & Associates fully exited iShares MSCI EAFE ETF in Q1 2014, selling an estimated $14.6M.
  • Chesley Taft & Associates's ten largest holdings make up 21% of its $933M portfolio in Q1 2014.
  • Chesley Taft & Associates opened 19 new positions and closed 38 in Q1 2014.
  • Chesley Taft & Associates's portfolio value fell 7% quarter-over-quarter to $933M.

Based on Chesley Taft & Associates's 13F filing for Q1 2014, filed 11 Apr 2014.